Quality Assurance in Immunohistochemistry: Results of an Interlaboratory Trial Involving 172 Pathologists
暂无分享,去创建一个
Thomas Rüdiger | H. Müller-Hermelink | H. Höfler | H. Kreipe | H. Nizze | M. Mengel | R. Wasielewski | R. von Wasielewski | T. Rüdiger | H. Fischer | H. Stein | H Höfler | M Mengel | F E Dallenbach | U. Pfeifer | H. Stein | F. Dallenbach | R von Wasielewski | H-H Kreipe | H Nizze | U Pfeifer | H Stein | H-P Fischer | H K Müller-Hermelink | H. Müller-hermelink | T. Rüdiger
[1] C. Taylor. Report from the Biological Stain Commission: FDA issues final rule for classification/reclassification of immunochemistry (IHC) reagents and kits. , 1998, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[2] Kraemer Bb. Quality assurance activities of the College of American Pathologists. , 1989 .
[3] G. J. Reynolds. External quality assurance and assessment in immunocytochemistry , 1989, Histopathology.
[4] S. Mills,et al. Consensual interpretive guidelines for diagnostic immunohistochemistry. , 2001, The American journal of surgical pathology.
[5] E. Campo,et al. Expression of cytokeratins in squamous cell carcinomas of the larynx: immunohistochemical analysis and correlation with prognostic factors. , 1993, Pathology, research and practice.
[6] T. Seidal,et al. Interpretation and Quantification of Immunostains , 2001, The American journal of surgical pathology.
[7] R. Rickert,et al. Intralaboratory quality assurance of immunohistochemical procedures. Recommended practices for daily application. , 1989, Archives of pathology & laboratory medicine.
[8] L. Bobrow,et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. , 2001, American journal of clinical pathology.
[9] D. Barnes,et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems , 2000, Journal of clinical pathology.
[10] C. Taylor. Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the Biological Stain Commission, June, 1991. , 1992, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[11] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] W. Remmele,et al. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer , 2004, Virchows Archiv A.
[13] C. Compton,et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. , 2000, Archives of pathology & laboratory medicine.
[14] B. Jasani,et al. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries , 2000, Journal of clinical pathology.
[15] C. Taylor. FDA issues final rule for classification and reclassification of immunochemistry reagents and kits. , 1999, American journal of clinical pathology.
[16] S. Martino,et al. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand‐binding assay compared with ER, PgR and pS2, by immuno‐histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study , 2000, International journal of cancer.
[17] P. Swanson. Diagnostic immunohistochemistry. A practical primer for the benighted bureaucrat. , 1993, American Journal of Clinical Pathology.
[18] R. Cote,et al. Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[19] C. Taylor,et al. Intracellular immunoglobulins , 1974, Journal of clinical pathology.
[20] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.
[21] J. Papadimitriou,et al. The total test approach to standardization of immunohistochemistry. , 2009, Archives of pathology & laboratory medicine.
[22] C. Compton,et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. , 2000, Archives of pathology & laboratory medicine.
[23] C. Taylor,et al. An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. , 1994, Human pathology.
[24] I. Lauder,et al. Comparative quality assessment in immunocytochemistry: pilot study of CD15 staining in paraffin wax embedded tissue in Hodgkin's disease. , 1989, Journal of clinical pathology.
[25] P. Swanson. Labels, disclaimers, and rules (oh, my!). Analyte-specific reagents and practice of immunohistochemistry. , 1999, American journal of clinical pathology.
[26] H. Höfler,et al. [Immunohistochemistry Circle Trial of the University Institute of Pathology in Germany]. , 1997, Der Pathologe.
[27] R. Cote,et al. Immunohistochemical markers of prognostic value in surgical pathology. , 1997, Histology and histopathology.